Low dose enoxaparin

DRUG2 trials

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Oregon Health and Science University

Conditions

Blood ClotsDeep Vein Thrombosis (DVT)Deep Venous ThrombosisPulmonary Embolism

Phase 4

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

CompletedNCT01828697

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Deep Venous Thrombosis, Pulmonary Embolism

Start: 2013-04-24End: 2021-10-31Updated: 2022-05-26

Below Knee DVT Study

TerminatedNCT03805672

Oregon Health and Science UniversityBlood Clots, Deep Vein Thrombosis (DVT)

Start: 2014-09-30End: 2015-07-31Updated: 2019-03-13

Related Papers

Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study.

2022-12-225 citations

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.

2022-10-2851 citations